- Males or females, without evidence of infection with HIV,HBV or HCV, who are on
chronic methadone maintenance for at least three months and at a stable dose for at
least 1 week prior to study start.
- Evidence of chronic diseases including HIV, HBV or HCV.
- Evidence of acute or chronic liver disease.
- Treatment with prescription or nonprescription drugs other than methadone within 7